BOC Sciences Establishes Optimal Route of APIs Production Through Microbial Fermentation
BOC Sciences recently announced that it has established an optimal route to produce APIs through microbial fermentation.
Shirley, United States – September 16, 2021 /MarketersMEDIA/ —
BOC Sciences, a well-known pharmaceutical company specializing in the research, development, and production of metabolites, recently announced that it has established an optimal route to produce APIs through microbial fermentation.
In the context of the COVID-19 pandemic, the supply of APIs, especially the COVID-19 vaccines, is really tight. Moreover, in the face of increasingly stringent environmental protection requirements, the shortage of raw materials has led to an increase in their prices. Therefore, it is necessary to find a cost-effective way to produce APIs is critical.
Nowadays, microbial fermentation can produce a large number of valuable pharmaceutical products, including antibiotics, amino acids, enzymes, enzyme inhibitors, nucleotides, vitamins, organic acids, vaccines, polysaccharides, etc. It has become an essential technology in pharmaceutical manufacturing. BOC Sciences’s microbial fermentation technology has the characteristics of short time-consuming, low cost, and low pollution, which provides an optimal economic route for pharmaceutical companies to shorten the production process and time to market.
BOC Sciences is a leading contract development and manufacturing company in the field of microbial fermentation, which specializes in fermentation-related projects that meet the needs of customers in the pharmaceutical, food, and agricultural industries. And it offers services for strain development, metabolic pathway engineering, strain improvement, protein expression, enzyme engineering and fermentation process development. In addition, BOC Sciences has extensive expertise in fermentation process optimization to find out the optimum combination fermentation conditions covering upstream fermentation to downstream process.
Comprehensive R&D platforms and scale-up fermentation
As a CDMO company, BOC Sciences has comprehensive R&D platforms and support facilities, as well as a comprehensive quality system, to supply total solutions for the development and biomanufacturing of a broad range of biological molecules. BOC Sciences not only has strong ability in the development of APIs and intermediates, but also has robust production capacity, which can support over 100,000 liters of large-scale fermentation production.
GMP compliant manufacturing
BOC Sciences has been committed to continuously and consistently assuring GMP compliance throughout its day-to-day operations across all sites. In the past years, GMP production sites of BOC Sciences are designed in strict accordance with US-FDA guidelines for GMP manufacturing and have passed US-FDA inspections many times.
GRAS certified strains
GRAS is an FDA designation that experts believe the substances added to food are safe. BOC Sciences can help clients complete GRAS evaluations and prepare the GRAS documentation to support the GRAS status of the ingredients. BOC Sciences’s strain gene identification platform ensures that the strains used in the project are of the GRAS level. BOC Sciences provides GRAS report, containing a full genome sequencing, potency, Gram staining, sugar fermentation, enzymatic activity, antibiotic strain resistance profile and proteome profile.
For more information about microbial fermentation of BOC Sciences, please visit the website: https://bio-fermen.bocsci.com.
About BOC Sciences
BOC Sciences has an experienced team of experts in the fields of microbiology, chemistry and biology, aiming to provide researchers in the fields of food safety, life sciences and pharmaceuticals with high-quality products and services related to microbial metabolites.
Contact Info:
Name: Alex Brown
Email: Send Email
Organization: BOC Sciences
Website: https://bio-fermen.bocsci.com
Source: MarketersMEDIA
Release ID: 89045750
Copyright © 1999-2013 SproutNews.com
